BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19563989)

  • 1. The pholcodine story.
    Florvaag E; Johansson SG
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):419-27. PubMed ID: 19563989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents.
    Harboe T; Johansson SG; Florvaag E; Oman H
    Allergy; 2007 Dec; 62(12):1445-50. PubMed ID: 17983379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six years without pholcodine; Norwegians are significantly less IgE-sensitized and clinically more tolerant to neuromuscular blocking agents.
    de Pater GH; Florvaag E; Johansson SG; Irgens Å; Petersen MN; Guttormsen AB
    Allergy; 2017 May; 72(5):813-819. PubMed ID: 27859358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market.
    Florvaag E; Johansson SG; Irgens Å; de Pater GH
    Allergy; 2011 Jul; 66(7):955-60. PubMed ID: 21241314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgE-mediated anaphylactic reactions to neuromuscular blocking agents: can they be prevented?
    Florvaag E; Johansson SG
    Curr Allergy Asthma Rep; 2008 Sep; 8(5):375-6. PubMed ID: 18682099
    [No Abstract]   [Full Text] [Related]  

  • 6. Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis.
    Brusch AM; Clarke RC; Platt PR; Phillips EJ
    Br J Clin Pharmacol; 2014 Jul; 78(1):14-23. PubMed ID: 24251966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is pholcodine a dangerous cough suppressant?
    Ing Lorenzini K; Desmeules J; Piguet V
    Eur J Anaesthesiol; 2015 Nov; 32(11):749-50. PubMed ID: 26426574
    [No Abstract]   [Full Text] [Related]  

  • 8. [New insights into the role of pholcodine in the treatment of cough in 2013?].
    Blanchard E; Tunon de Lara M
    Therapie; 2013; 68(2):85-91. PubMed ID: 23773349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid non-IgE mediated effects in a BAT assay on drug hypersensitivity to pholcodine.
    Chirumbolo S
    Cytometry B Clin Cytom; 2014 Mar; 86(2):77. PubMed ID: 24030936
    [No Abstract]   [Full Text] [Related]  

  • 10. IgE-mediated allergy to pholcodine and cross-reactivity to neuromuscular blocking agents: Lessons from flow cytometry.
    Leysen J; De Witte L; Sabato V; Faber M; Hagendorens M; Bridts C; De Clerck L; Ebo D
    Cytometry B Clin Cytom; 2013 Mar; 84(2):65-70. PubMed ID: 23355309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between pholcodine and perioperative anaphylaxis].
    Dumancić J; Marković AS
    Acta Med Croatica; 2012 May; 66(2):111-4. PubMed ID: 23437637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to letter regarding article 'Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis'.
    Brusch AM; Clarke RC; Platt PR; Phillips E
    Br J Clin Pharmacol; 2014 Oct; 78(4):931-2. PubMed ID: 24611979
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurement of pholcodine-specific IgE in addition to morphine-specific IgE improves investigation of neuromuscular blocking agent anaphylaxis.
    Anderson J; Green S; Capon M; Krupowicz B; Li J; Fulton R; Fernando SL
    Br J Anaesth; 2020 Dec; 125(6):e450-e452. PubMed ID: 32600804
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter to the authors concerning the accepted manuscript: exploring the link between pholcodine and neuromuscular anaphylaxis by Brush et al.
    Uyttebroek A; Leysen J; Bridts C; Ebo D
    Br J Clin Pharmacol; 2014 Oct; 78(4):929-30. PubMed ID: 24611952
    [No Abstract]   [Full Text] [Related]  

  • 15. Stability of a 1.0 mg ml(-1) aqueous pholcodine solution for allergy skin testing.
    Barbier P; Scala-Bertola J; Gambier N; Rivier A; Demoré B; Gillet P; Nicolas A; Petitpain N
    Br J Clin Pharmacol; 2014 Nov; 78(5):1172-4. PubMed ID: 24903072
    [No Abstract]   [Full Text] [Related]  

  • 16. Perioperative anaphylaxis.
    Mertes PM; Lambert M; Guéant-Rodriguez RM; Aimone-Gastin I; Mouton-Faivre C; Moneret-Vautrin DA; Guéant JL; Malinovsky JM; Demoly P
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):429-51. PubMed ID: 19563990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pholcodine caused anaphylaxis in Sweden 30 years ago.
    Johansson SG; Oman H; Nopp A; Florvaag E
    Allergy; 2009 May; 64(5):820-1. PubMed ID: 19210354
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively.
    Florvaag E; Johansson SG; Oman H; Venemalm L; Degerbeck F; Dybendal T; Lundberg M
    Acta Anaesthesiol Scand; 2005 Apr; 49(4):437-44. PubMed ID: 15777289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pholcodine stimulates a dramatic increase of IgE in IgE-sensitized individuals. A pilot study.
    Florvaag E; Johansson SG; Oman H; Harboe T; Nopp A
    Allergy; 2006 Jan; 61(1):49-55. PubMed ID: 16364156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to Chirumbolo.
    Leysen J; Bridts C; Ebo DG
    Cytometry B Clin Cytom; 2014 Mar; 86(2):78-9. PubMed ID: 24127291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.